Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Neeraj Agarwal
Sep 15, 2024, 15:11 |
Insight
Myriam Chalabi's highlights from ESMO24
The ESMO Congress 2024 (ESMO24) is one of the most globally influential platforms in oncology, bringing…
Sep 15, 2024, 12:53 |
Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 17:15 |
Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 7, 2024, 15:45 |
Blog
Dimitra R. Bakaloudi: Evaluating TMB and MSI in patients with Urothelial cancer treated with ICIs
Dimitra R. Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X about…
Sep 7, 2024, 10:04 |
Blog
Jun Gong: Selective omission of RT in rectal cancer
Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared on X:…
Sep 1, 2024, 08:30 |
Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Aug 10, 2024, 12:17 |
Insight
Emmanuel Antonarakis: Most compelling study suggesting that combined Abiraterone and Olaparib is better than sequential Abiraterone and Olaparib for 1st-line mCRPC
Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, shared a post on X…
Aug 5, 2024, 01:55 |
Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 4, 2024, 16:52 |
Insight
Future of ADCs and targeted therapies in bladder cancer
Neeraj Agarwal shared a post on X: “Future of ADCs and targeted therapies in bladder…
Aug 4, 2024, 14:30 |
Societies
8 Posts Not To Miss From GUWorld24!
The 2024 World Conference On Genitourinary Cancers (GUWorld24) took place from August 1st to 3rd…
4
5
6
7
8
All:
91
Posts:
51 - 60
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube